Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome
- 1 February 2010
- journal article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 23 (2), 213-224
- https://doi.org/10.1038/modpathol.2009.160
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motilityMolecular Cancer Therapeutics, 2008
- E-cadherin loss and ΔNp73L expression in oral squamous cell carcinomas showing aggressive behaviorHead & Neck, 2008
- KCl Cotransporter-3 Down-regulates E-Cadherin/β-Catenin Complex to Promote Epithelial-Mesenchymal TransitionCancer Research, 2007
- Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinomaHistopathology, 2007
- Vimentin and Epithelial-Mesenchymal Transition in Human Breast Cancer – Observations in vitro and in vivoCells Tissues Organs, 2007
- Altered E‐cadherin/β‐catenin expression in oral squamous carcinoma with and without nodal metastasisOral Diseases, 2007
- Aberrant expression of β- and γ-catenin is an independent prognostic marker in oral squamous cell carcinomaInternational Journal of Oral & Maxillofacial Surgery, 2006
- A comparative study of the clinicopathological significance of E-cadherin and catenins (α, β, γ) expression in the surgical management of oral tongue carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- Head and Neck CancerThe New England Journal of Medicine, 1993
- Cadherin Cell Adhesion Receptors as a Morphogenetic RegulatorScience, 1991